Improvement in pain severity category in clinical trials of pregabalin

BACKGROUND: Pregabalin is approved by the US Food and Drug Administration for the treatment of fibromyalgia (FM), diabetic peripheral neuropathy (DPN), postherpetic neuralgia (PHN), and neuropathic pain due to spinal cord injury (SCI). Approval was based on clinical trial data demonstrating statisti...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Pain Res
Asıl Yazarlar: Parsons, Bruce, Argoff, Charles E, Clair, Andrew, Emir, Birol
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2016
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5063480/
https://ncbi.nlm.nih.gov/pubmed/27785092
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S102696
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller